InsidersTradesSigma
Follow the 3SBio Inc. share price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares trade on the HK market, under the authority of HKEX. Market capitalisation: €6.6bn. The latest transaction was filed on 7 September 2026 (Purchase). Among the most active insiders: Lou Jing. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3SBio Inc. is a Chinese biopharmaceutical company focused on the research, development, and commercialization of biological products. It primarily targets treatments for kidney diseases and blood disorders.